| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/19/2008 | US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2369448C Medicament for inhibiting nf-kb |
| 08/14/2008 | WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease |
| 08/14/2008 | WO2008097510A1 Antibodies specific for dkk-1 |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096826A1 Prophylactic agent for autoimmune disease |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof |
| 08/14/2008 | WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors |
| 08/14/2008 | WO2008096028A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
| 08/14/2008 | WO2008095944A1 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 08/14/2008 | WO2008095679A1 Use of bartonella quintana derived lipopolysaccharide for the treatment of autoimmune, autoinflammatory or infectious diseases |
| 08/14/2008 | WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof |
| 08/14/2008 | WO2007059209A9 Extract of dioscorea sp. and the medical uses thereof |
| 08/14/2008 | US20080194688 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 08/14/2008 | US20080194682 administering inhibitors of endopeptidase such as thiorphan or candoxatril, to effect bone elongation; achondroplasia |
| 08/14/2008 | US20080194676 Formulations for oral administration of cromolyn sodium |
| 08/14/2008 | US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease |
| 08/14/2008 | US20080194640 Optically Active Tetrahydronaphthalene Derivative |
| 08/14/2008 | US20080194614 Using mixture of hydroxy-3-methylglutaryl coenzyme a inhibitor and rapamycin; anticholesterol agents; dyslipidemia; atherosclerosis; antiarthritic agents; inflammatory bowel disorders; restenosis; transplant rejection |
| 08/14/2008 | US20080194584 Nitrogen Heteroaromatic Compounds Which Bind To The Active Site Of Protein Kinase Enzymes |
| 08/14/2008 | US20080194565 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases |
| 08/14/2008 | US20080194541 Anti-Inflammatory Agents |
| 08/14/2008 | US20080194538 Including inflammatory pain, post surgical pain, and neuropathic pain; administering a histamine H4 receptor ligand alone or in combination with a histamine H1, H2, or H3 receptor antagonist or an enzyme inhibitor |
| 08/14/2008 | US20080194533 Sulfating 17 beta-dihydroequilin or 17 beta-estradiol using tertiary amine-sulfur trioxide complexes and sodium, lithium or potassium salt formation; hormone replacement therapy; hot flashes in postmenopausal women; endometriosis, breast cancer |
| 08/14/2008 | US20080194493 Compositions Containing D-Carnosine |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080193564 Method for preventing or reducing secondary fractures after hip fracture |
| 08/14/2008 | US20080193560 Use of arsenic compounds for treatment of pain and inflammation |
| 08/14/2008 | US20080193559 Pain relief composition comprising paramagnetic silver nanoparticles |
| 08/14/2008 | US20080193549 Hoki Fish Liver Oil, Fractions Thereof And Therapeutic Uses |
| 08/14/2008 | US20080193517 Polymer Conjugates of K-252A and Derivatives Thereof |
| 08/14/2008 | US20080193515 Overexpression of Wnt ligands and treatment of lytic bone diseases |
| 08/14/2008 | US20080193501 Synergistic; proliferative agents for bone and nervous tissue; can also include an antiinflammatory agent to treat rheumatoid or osteoarthritis; time-release formulations in dosage forms of solutions, gels, pastes or putties |
| 08/14/2008 | US20080193500 Aggrecan; collagen; heteropolysaccharide in extracellular matrix |
| 08/14/2008 | US20080193425 Methods for administering fgf18 |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677356A1 Antibodies specific for dkk-1 |
| 08/14/2008 | CA2677233A1 Prophylactic agent for autoimmune disease |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels |
| 08/13/2008 | EP1956015A2 Polymorph of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same |
| 08/13/2008 | EP1956014A2 Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same |
| 08/13/2008 | EP1954677A1 Thiomorpholine compound and process for preparing the same |
| 08/13/2008 | EP1954291A1 Treatment and prevention of bone loss using resolvins |
| 08/13/2008 | EP1954280A2 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 08/13/2008 | EP1758870B1 4-phenyl-pyrimidine-2-carbonitrile derivatives |
| 08/13/2008 | EP1565183B1 Rapamycin and il-10 for the treatment of autoimmune diseases |
| 08/13/2008 | EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof |
| 08/13/2008 | EP1489076B1 Cyclic hemiacetal derivative and use thereof |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP1213028B1 Hm1.24 antigen expression potentiators |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | EP0996448B1 Treatment and prevention of adhesions |
| 08/13/2008 | EP0936913B1 Oral pharmaceutical preparation containing ibandronat |
| 08/13/2008 | CN101243056A Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 08/13/2008 | CN101242821A Novel use of peptide compounds for treating muscle pain |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239959A Benzopyrone derivative, preparation method and medical use thereof |
| 08/13/2008 | CN101239172A Medicinal composition for curing necrosis of femoral head and preparation thereof |
| 08/13/2008 | CN101239168A Composition with ease pain anti-inflammatory action |
| 08/13/2008 | CN101239159A Chinese medicinal composition for treating rheumatoild disease and preparation thereof |
| 08/13/2008 | CN101239154A Medicament for treating protrusion of lumbar vertebral disc and pain of neck, shoulder, waist and leg bone and preparation thereof |
| 08/13/2008 | CN101239136A Medicament for treating rheumatism |
| 08/13/2008 | CN101239133A Externally-applied plaster for treating protrusion of lumbar intervertebral disc |
| 08/13/2008 | CN101239132A Strong bone-setting medicament for treating bone fracture and traumatic injury |
| 08/13/2008 | CN101239131A Blood-stasis-dissipating blood-circulation-promoting fast fracture-setting medicament |
| 08/13/2008 | CN101239115A Medicaments for treating pain of knee joint |
| 08/13/2008 | CN101239109A Externally-applied plaster for eliminating bony spur and preparation technique |
| 08/13/2008 | CN101239100A Application of Sichuan chinaberry extract in pharmaceutical and extracting method thereof |
| 08/13/2008 | CN101239092A Kudzuvine flower isoflavonoid extraction, its extracting method, medicinal composition and its use in pharmaceutical |
| 08/13/2008 | CN101239083A New medical purpose of privet and pharmaceutical formulation thereof |
| 08/13/2008 | CN101239038A Aminoglucose injection and preparation thereof |
| 08/13/2008 | CN100410388C Method for identifying compound of increasing bone mineral substance density |
| 08/13/2008 | CN100410384C Retrovirus carrier of bone morphogenetic protein 4 gene and its use |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100409886C Medicinal liquor for bone health |
| 08/13/2008 | CN100409877C Chinese medicine preparation for treating hyperosteogeny |
| 08/13/2008 | CN100409872C External-dressing Chinese medicine for bone-setting treatment |
| 08/13/2008 | CN100409861C Eshu oil |
| 08/13/2008 | CN100409857C Chinese medicine preparation for resisting osteoporosis |
| 08/13/2008 | CN100409851C Soy daidzin composition and preparation process and use thereof |
| 08/13/2008 | CN100409842C Heiguidou oil |
| 08/13/2008 | CN100409840C Application of inhibitors of glycogen synthase kinase-3 betta in preparing medicament for increasing bone formation |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |